Mankind Pharma Q2

Mankind Pharma Q2 Profit Soars 30% To Rs 653 Crore

 India's Mankind Pharma reported a stronger-than-expected profit for the second quarter of FY24, driven by higher demand for its medications targeting long-term health conditions like diabetes and cardiovascular diseases. For the quarter ending September 30, the company's consolidated net profit reached Rs 653 crore ($77.7 million), marking a 30% increase...